baber/WOPTO huggingface dataset:
Patent PT-2057835-E (PT)
Title: Method of reducing the residual acoustic echo after echo removal in a hands-free device
Inventor: SEYDOUX HENRI
IPC: H04M9/08
Filed: 2007-08-10
Abstract: The method involves suppressing residual echo remaining after the execution of processing of echo cancellation, in frequency field and on successive frames of audio signal. Ambient noise (34) in the signal is reduced after the processing of echo cancellation. Respective values of power of residual echo are estimated on a set of frequency bands defined for the successive frames of the signal. A variable gain to each frequency band and to each frame is calculated, where respective gain being as weak as relative power estimated from the residual echo is elevated.
Patent PT-2009807-E (PT)
Title: Distributor power line communication system
Inventor: HENDERIECKX LUC
IPC: H04B3/54
Filed: 2008-03-18
Abstract: Distributor power line communication system comprising a communication server (1) sending and receiving messages over a telecommunication network (2), a power distribution substation (3) to which a power distribution network (4) towards end users (5) is connected, at least one gateway (6; 18) transferring messages from the telecommunication network (2) onto the power distribution network (4) in a predetermined frequency band, a plurality of smart metering devices (7; 17; 27) at end user mains networks for measuring power consumption and comprising a power line communication modem (8; 18) sending and receiving messages within the predetermined frequency band over the power distribution network (4), power line communication filters (10, 11) on power lines connecting the power distribution network and the end user mains networks and on power lines connecting the power distribution network to the power distribution substation, each filter blocking frequencies within the predetermined frequency band.
Patent PT-2139527-E (PT)
Title: Quantitative liquid injection device of plasma sterilizer
Inventor: KO JUNG SUEK
IPC: A61L2/14
Filed: 2008-02-21
Abstract: Disclosed herein is a device for quantitatively supplying a liquid in a plasma sterilization system. The device includes a quantitative cylinder, a quantitative piston and a quantitative basket. The quantitative cylinder includes a quantitative inlet pipe, which is configured such that the outlet of a liquid container is inserted thereinto, and a liquid in the liquid container is vertically supplied to the quantitative cylinder, and a quantitative outlet pipe, which is configured such that the liquid is vertically drained from the quantitative cylinder. The quantitative piston is configured to rectilinearly reciprocate in the quantitative cylinder, and is provided with a quantitative transfer depression, which is formed in the leading end thereof to a predetermined depth. The quantitative basket is configured to quantitatively receive the liquid according to the rectilinear reciprocation of the quantitative piston.
Patent PT-2214760-E (PT)
Title: Metering device for inhaling a powdery substance
Inventor: SCHUCKMANN ALFRED VON
IPC: A61M15/00
Filed: 2008-10-29
Abstract: A dosing device can be activated by a vacuum air stream of a user for the inhalation of a powder substance, particularly medicine, which is arranged in a supply chamber and which can be brought out of the same into an open emptying-ready position by a dosing chamber of a dosing rod when the mouthpiece-closure cap is removed. In particular, in order to improve dispensing, the provision of two air paths, of which one serves to open and empty the dosing chamber, and/or the second air path penetrates directly into a ring chamber in order to mix with the air flow containing the substance.
Patent PT-2308977-E (PT)
Title: Novel herbicide resistance gene
Inventor: MERLO DONALD J
IPC: C12N9/02
Filed: 2005-05-02
Abstract: The subject invention provides novel plants that are not only resistant to 2,4-D and other phenoxy auxin herbicides, but also to aryloxyphenoxypropionate herbicides. Heretofore, there was no expectation or suggestion that a plant with both of these advantageous properties could be produced by the introduction of a single gene. The subject invention also includes plants that produce one or more enzymes of the subject invention alone or "stacked" together with another herbicide resistance gene, preferably a glyphosate. resistance gene, so as to provide broader and more robust weed control, increased treatment flexibility, and improved herbicide resistance management options. More specifically, preferred enzymes and genes for use according to the subject invention are referred to herein as AAD (aryloxyalkanoate dioxygenase) genes and proteins. No ±-ketoglutarate-dependent dioxygenase enzyme has previously been reported to have the ability to degrade herbicides of different chemical classes and modes of action. This highly novel discovery is the basis of significant herbicide tolerant crop trait opportunities as well as development of selectable marker technology. The subject invention also includes related methods of controlling weeds. The subject invention enables novel combinations of herbicides to be used in new ways. Furthermore, the subject invention provides novel methods of preventing the formation of, and controlling, weeds that are resistant (or naturally more tolerant) to one or more herbicides such as glyphosate.
Patent PT-2296282-E (PT)
Title: Method and device for arithmetic encoding and decoding with use of multiple lookup tables
Inventor: MARPE DETLEV
IPC: H03M7/40
Filed: 2003-05-02
Abstract: The method involves dividing a value range specifying the interval width into representative interval widths and a value range specifying probabilities into representative probability states, defining rules that associate each interval width and probability and computing new interval widths using a representative interval width and probability state, various arithmetic operations and a probability estimation according to the defined rules. The method involves dividing a defined value range for specifying the interval width into representative interval widths and a definable value range for specifying probabilities into representative probability states and defining association rules that associate each interval width and each probability, encoding or decoding the binary states by computing new interval widths using a representative interval width and probability state, various arithmetic operations and a probability estimation in accordance with the defined association rules. Independent claims are also included for the following: (a) an arrangement with at least one processor and/or chip for arithmetically encoding and decoding binary states (b) a computer program for arithmetically encoding and decoding binary states (c) a computer-readable memory medium for storing a computer program for arithmetically encoding and decoding binary states (d) a method of downloading a computer program from an electronic data network, e.g. Internet.
Patent PT-655056-E (PT)
Inventor: HANSON GUNNAR J
IPC: C07D471/08
Filed: 1993-02-24
Abstract: Compounds characterized generally as piperidinyl-terminated alkylamino ethynyl alanine amino diol derivatives are useful as renin inhibitors for the treatment of hypertension. Compounds of particular interest are those of Formula I  (* CHEMICAL STRUCTURE *) (I) wherein A is selected from CO and SO2; wherein X is selected from oxygen atom and methylene; wherein B is selected from a piperidinyl group, an isoindolyl group and an azabicyclononyl group; wherein R1 is selected from hydrido, methyl, ethyl, isopropyl and n-propyl; wherein R2 is phenylmethyl; wherein each of R3 and R5 is hydrido; wherein R4 is selected from  (* CHEMICAL STRUCTURE *)  wherein V is selected from hydrido and methyl; wherein R6 is cyclohexylmethyl; wherein R7 is selected from isobutyl, cyclopropyl and cyclopropylmethyl; wherein q is a number selected from zero through three, inclusive; and wherein n is a number selected from zero through three, inclusive; or a pharmaceutically-acceptable salt thereof.
Patent PT-878198-E (PT)
Inventor: GOTO TAKESHI
IPC: A61K9/20
Filed: 1996-08-02
Abstract: The present invention relates to a pharmaceutical composition comprising anion exchange resin, silicon dioxide, crystalline cellulose, and pharmaceutically acceptable carriers and more particularly to tablets containing anion exchange resin prepared by mixing anion exchange resin, silicon dioxide and crystalline cellulose without adding water and tabletting the mixture. More preferably, the present invention relates to said pharmaceutical composition or tablets wherein the anion exchange resin is non-crosslinked anion exchange resin represented by the formula (I): <CHEM> wherein R1 is an aralkyl group having from 7 to 10 carbon atoms or An alkyl group having from 1-20 carbon atoms; R2 and R3 are each independently the same or different and represent a lower alkyl group having from 1-4 carbon atoms; R4 is a hydrogen atom or a lower alkyl group having 1-4 carbon atoms; X is a physiologically acceptable counter ion; n is an integer of from 1 to 3; and p is an average degree of polymerization of from 10 to 10,000.
Patent PT-873123-E (PT)
Inventor: SEBTI SAID M
IPC: A61K31/216
Filed: 1996-11-05
Abstract: Compounds having formula (I) or a pharmaceutically acceptable salt thereof wherein R1 is selected from: (a) hydrogen, (b) loweralkyl, (c) alkenyl, (d) alkoxy, (e) thioalkoxy, (f) halogen, (g) haloalkyl, (h) aryl-L2 - and (i) heterocyclic - L3; R2 is selected from the group consisting of: (a) formula (II), (b) -C(O)NH-CH(R14)-C(O)OR15, (c) formula (III), (d) -C(O)NH-CH(R14)-C(O)NHSO2R16, (e) -C(O)NH-CH(R14)-tetrazolyl, (f) -C(O)NH-heterocyclic, and (g) -C(O)NH-CH(R14)-C(O)NR17R18; R3 is pyridyl, substituted pyridyl, imidazolyl, or substituted imidazolyl; R4 is selected from hydrogen, lower alkyl, haloalkyl, halogen, aryl, arylakyl, heterocyclic, and (heterocyclic)alkyl; and L1 is absent or is selected from (a) -L4-N(R4)-L5-, (b) -L4-O-L5-, (c) -L4-S(O)n-L5-, (d) -L4-L6-C(W)-N(R5)-L5-, (e) -L4-L6-S(O)m-N(R7)-L5-, (f) -L4-N(R7)-C(W)-L7-L5-, (g) -L4-N(R7)-S(O)p-L7-L5-, (h) C2-C4-alkylene optionally substituted with 1 or 2 hydroxy groups, (i) C2-to-C4-alkenylene, and (j) C2-to-C4-alkynylene, are inhibitors of protein isoprenyl transferases. Also disclosed are protein isoprenyl transferase inhibiting compositions and a method of inhibiting protein isoprenyl transferases.
Patent PT-779508-E (PT)
Inventor: STAVRIDI MARIGO
IPC: G01N21/78
Filed: 1994-04-01
Abstract: A glucose monitor, and related method, determines the concentration of glucose in a sample by monitoring fluorescent light produced directly by any glucose present in the sample. The glucose monitor illuminates the sample with ultraviolet excitation light that induces any glucose present in the sample to fluoresce, with the fluorescent light being monitored and processed to determine the concentration of glucose in the sample. A sensor monitors the return light, which includes fluorescent light produced by any glucose in the sample, and generates first and second electrical signals indicative of the intensity of light in two wavelength bands. One wavelength band includes a characteristic spectral peak of glucose fluorescence, and the other wavelength band is a reference band having known spectral characteristics. A processor then processes the first and second electrical signals to determine the concentration of glucose in the sample. A fiber-optic waveguide is used to guide the excitation light from the laser light source to the sample and the return light from the sample to the sensor. The fiber-optic waveguide is housed in a catheter or probe that is adapted to monitor the concentration of glucose percutaneously in the oral cavity tissues of a person's mouth such as the gums. <IMAGE>
Patent PT-906139-E (PT)
Inventor: THIBERG ROLF
IPC: A61N5/06
Filed: 1997-06-04
Abstract: Apparatus for external medical treatment with light. A light-emitting device is provided that is adapted to be held in close proximity to the body of an individual and that includes light-emitting diodes or corresponding elements that are adapted to emit monochromatic light of a first wavelength. The light emitting device is driven by a drive arrangement for causing the light-emitting device to emit the monochromatic light over a first predetermined time period in a first state, and thereafter emit selectively monochromatic light of a different wavelength than the first wavelength and over a second predetermined time period in a possible second state. The drive arrangement causes the light-emitting device to pulsate the emitted light in accordance with a predetermined pulse frequency or series of pulse frequencies over the respective time periods, and causes the light-emitting device to emit the pulsating light with a pulse length that lies within an interval of about 60% to about 90% of the time between respective start edges of two mutually sequential pulses.
Patent PT-915818-E (PT)
Inventor: ROCHIN CHRISTOPHE
IPC: C07C45/86
Filed: 1997-07-16
Abstract: Acids having a pKa of less than about 4 may be used to stabilize certain perfluoroalkyl alkyl ketones, particularly a substantially pure perfluoroalkyl alkyl ketone, a substantially pure aqueous solution of a perfluoroalkyl alkyl ketone or a substantially pure hydrate of a perfluoroalkyl alkyl ketone.
Patent PT-863355-E (PT)
Inventor: DOMINGUEZ RAMON PALAU
IPC: F16L33/08
Filed: 1997-07-31
Abstract: Improvements to the construction of metal brackets with screw for the clamping or tightening thereof, the vertices of the extremities of the two arms of the front cross-bar at the body-tunnel entrance are enlarged, and a space is provided for the housing thereof into the screw body, with concentric bearing flange and double clamping tailpiece of the two ends of the metal strip coiled from the tunnel base being substituted by a transverse monotailpiece which is rabated to the opposite side, with a threaded tongue for clasping purposes, and one of the extremities of the strip having two juxtaposed drawn pieces, one in the upper surface and the other one in the lower surface of crimping with the edge of the transverse monotailpiece, the upper one impeding the excessive elevation of the proper extremity. <IMAGE>
Patent PT-986661-E (PT)
Inventor: DERUD PIERRE
IPC: D04B21/16
Filed: 1998-06-05
Abstract: A reinforcing web constituted by substantially parallel and spaced-apart warp threads and by pairs of reinforcing threads, each shaped in the form of successive half-loops alternating in a weft direction. The successive half-loops of the reinforcing threads in each pair extend in opposite directions, and the pairs of threads are spaced apart from one another in such manner that the half-loops of the threads corresponding to two successive pairs overlap and together define closed loops which are set by means of flexible binding stitches formed in the overlap zones between the two half-loops and the warp threads. At least some of the reinforcing threads are constituted by metal tows. The reinforcing web is suitable for application to the seats of public transport vehicles.
Patent PT-1075348-E (PT)
Inventor: WILDENBERG FRANCOIS
IPC: F15B11/16
Filed: 1999-04-27
Abstract: A hexapod, for example, a hexapod used to position a tool with respect to a part to be machined, includes two spaced plates interconnected by six articulated and extensible legs. The two plates, including a base plate and a mobile plate, and the six legs are joined for varying, at will, the relative position of the mobile plate with respect to that of the base plate. The hexapod further includes a device for reducing and/or compensating for stresses on the elements of the hexapod, which can be a mechanical device, such as a jack, coupling a fixed surface with the periphery of the mobile plate and/or logic (in software) for defining at least one force-limiting criterion.
Patent SG-36493-G (SG)
Title: Wellhead seals
IPC: F16J15/48
Filed: 1993-03-31
Abstract: A seal assembly for sealing across the annulus in a subsea wellhead having pressure enhancement provided behind at least one of the sealing surfaces to ensure a positive metal-to-metal sealing. In a preferred form of the invention the seal assembly 20 min  includes upper sealing lips 30, 30a, 32, 32a, which diverge upwardly away from each other into sealing engagement with the sealing surfaces against which they are to seal, lower sealings lips 38, 38a, 40, 40a, which diverge downwardly away from each other into sealing engagement with the sealing surfaces against which they are to seal, and one or more rims 58, 60, 62, 64 secured to one of the wellhead members and spaced therefrom to provide a recess behind the rim and open to pressure which is directed toward the sealing lip which is to seal against such sealing surface to provide a pressure energized enhancement of the sealing engagement of the lips against said sealing surface. In other forms of the invention at least one of the rims may be used.
Patent IE-830086-L (IE)
Title: Nonwoven for medical compresses
IPC: D04H5/00
Filed: 1983-01-18
Abstract: PCT No. PCT/FR82/00211 Sec. 371 Date Sep. 28, 1983 Sec. 102(e) Date Sep. 28, 1983 PCT Filed Dec. 16, 1982 PCT Pub. No. WO83/02630 PCT Pub. Date Aug. 4, 1983.Curled non-woven material formed of waves such as contiguous anti-nodes (9,10) of adjacent waves consist of small adjacent pads (11,12) located on the same side of the median plan (8) of the non-woven material. Use: Medical and surgical compresses FIG. 3.
Patent IE-790098-L (IE)
Title: Solvent vehicle
IPC: A61K47/20
Filed: 1979-01-30
Abstract: The invention relates to a solvent vehicle for therapeutics comprising a dialkyl ester of adipic acid and, optionally, DMSC, which is particularly useful for therapeutic materials having a low solubility or being insoluble in water. The invention further relates to pharmaceutical compositions which are suitable for parental administration, especially by intramuscular injection, comprising a therapeutically active material dissolved in said solvent vehicle. Solvent vehicles containing di-n-butyl adipate and DMSO, and, if desired, one or more adjuvants, are preferred. Particularly useful are pharmaceutical compositions for the prophylaxis and or treatment of diseases caused by internal parasites, which can be administered by intramuscular injection. A preferred embodiment of the invention is an injectable composition against distomatosis (liver fluke disease) containing proportionally 12.5 g 4,6'-dichloro-4',6-dinitro-2,2'-methylene-diphenol and 30 g of DMSO, completed with di-n-butyl adipate to 100 cm3.[EP0003382A1]
Patent IE-820328-L (IE)
Title: Illumination system
IPC: F21K99/00
Filed: 1982-02-16
Abstract: An improved apparatus for illuminating a display, such as a lens, includes a source of nonwhite light of a first color at an energy level which can be perceived by the human eye. The nonwhite light of a first color is reflected from a reflector to obtain white light. In one embodiment of the invention, the nonwhite light source was a solid state device (light emitting diode) which produced blue light at a high-energy level and green and red light at relatively low energy levels with the result that the green and red light could not be perceived by a human eye simultaneously with the blue light. The light from the solid state light source was reflected from a reflector having a gold (yellow) reflecting surface. The light reflected from the reflecting surface interfered with light emitted directly form the solid state light source with a chromatic shift of light energy. The resulting light from the reflector was white light.
[US5743629A]
Patent IE-37382-L (IE)
Title: Tyres, interior lubrication
IPC: B60C15/00
Filed: 1973-03-07
Abstract: 1427713 Lubricating deflated pneumatic tyres DUNLOP Ltd 7 March 1973 [11 March 1972] 11510/72 Heading B7C A wheel and pneumatic tyre assembly includes adjacent at least one bead an annular container 3 filled with lubricant, which container is squeezed between and ruptured by opposed surfaces of the tyre upon deflation to facilitate lubrication of contacting surfaces of the tyre. The container includes a portion 10 (18) of lower extensibility than the portion 11 (19) and an integral flap 5 which may be reinforced by a cord fabric 6. The flap may be attached to a flap 8 of rubberized cord fabric integral with the bead by stapling (Fig. 1), stapled to a fabric flap (12) which in turn is secured to the bead (Figs. 2 and 3, not shown), trapped between the bead and wheel rim (Fig. 4, not shown), attached by studs 16 of metal, rubber or plastics received in circumferential spaced holes in the bead (Fig. 5) or trapped between the latter and bead retaining devices 20. Each form of attachment except that of Fig. 5 may be employed with the flap 5 also being adhered to the flap 8 (or 12) or to the tyre bead, as appropriate. The sidewall 10 of the container is thicker than the other sidewall (e.g. 2 mm. and 1 mm.). The difference in extensibility may be achieved in Fig. 5 by using different rubber compounds or incorporating a reinforcing cord fabric in sidewall 18.
[GB1427713A]
Patent IE-880963-L (IE)
Title: Psychotropic polycyclic imides
IPC: C07C61/125
Filed: 1988-03-30
Abstract: Substituted imides of the following formula are antipsychotic, anxiolytic agents with very little extrapyramidal side effects: <CHEM> in which X is -O-, -S-, -SO-, -SO2-, -CR3R4- where R3 and R4, independently, are hydrogen, alkyl of 1 to 4 carbon atoms or, taken together with the carbon atom to which they are attached, R3 and R4 form a cycloalkyl group of 3 to 5 carbon atoms; n is one of the integers 2, 3, 4 or 5; R is phenyl, alkylphenyl in which the alkyl group contains 1 to 4 carbon atoms, halophenyl, trifluoromethylphenyl, alkoxyphenyl, in which the alkoxy substituent contains 1 to 3 carbon atoms, 2-pyrimidinyl, halopyrimidin-2-yl, 2-pyrazinyl, halopyrazin-2-yl, 2-pyridinyl, cyanopyridin-2-yl, halopyridin-2-yl, quinolyl, or haloquinolyl; R1 and R2, taken together, are alkylene of 3 to 5 carbon atoms or alkenylene of 3 to 5 carbon atoms, or taken with the carbon atoms to which they are attached, R1 and R2 complete a benzene ring, or a group of the formula: <CHEM> where Y is -CH2, -CH2-CH2-, -O- or -S- and the dotted line represents optional unsaturation; or a pharmaceutically acceptable salt thereof. In addition, the intermediate b3-dicarboxylic and the corresponding anhydrides - 2,3,3a,4,5,6,6a,7,7a-decahydro-4,6,7-metheno-1H-cyclopena[a]pentalene-1,3 -dicarboxylic acid and octahydro-1, 5-methano-6,8,9-metheno-pentaleno[1,2,-d]oxepin-2,4(1H, 5H)-dione represent especially significant aspects of the invention.
Patent FI-830662-L (FI)
Inventor: BERNARD JEAN
IPC: A63C9/18
Filed: 1983-03-01
Abstract: The cross-country skiing assembly comprises a ski shoe and a ski binding for fixing the shoe on a ski. A toe block at the front end of the shoe has a fastening contour which is capable of cooperating with a complementary fastener on a shoe-retaining stirrup of the ski binding. A spring-loaded locking and releasing lever of the ski binding permits automatic positioning of the ski shoe by downward engagement. The shoe-retaining stirrup is pivotally mounted on a cross-pin which is adjacent to the front end face of the toe block.
Patent IE-781100-L (IE)
Title: Amidine phosphonates.
IPC: C07C/
Filed: 1978-05-31
Abstract: Amidine phosphonate compounds have the structure in which Het is a 5- or 6- membered unsaturated nitrogen heterocycle, Z is sulphur or methylene, n is 2 or 3, R1 is hydrogen, lower alkyl or Het-CH2Z(CH2)n-, p is 0 or 1, R2 is hydrogen or lower alkyl, or R1 and R2 together form a (CH2)2 or (CH2)3 group, R3 is lower alkyl, aryl or aryl(lower alkyl), and R4 18 hydrogen when p is 0 and hydrogen, lower alkyl, aryl or aryl(lower alkyl) when p is 1. Those compounds where R4 is other than hydrogen are intermediates for the preparation of the compounds where R4 is hydrogen, which have histamine H2-antagonist activity and are the active ingredients of pharmaceutical compositions. The compounds are prepared by primary amine coupling reactions, phosphonylation and hydrolysis.
[CA1096384A]